Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm motility refers to the ability of sperm cells to move actively and efficiently, particularly in a progressive manner, which is essential for reaching and fertilizing the oocyte. Sperm viability represents the proportion of living sperm, typically assessed by their intact membranes and metabolic activity. These parameters are primary indicators of male fertility and are affected by molecular pathways including energy production (mitochondrial function), ion channel activity (such as calcium and pH regulation), oxidative stress responses, and signal transduction (such as cAMP/PKA pathways). They are clinical endpoints used in diagnosis and treatment evaluation, but are not single molecular entities and do not correspond to a canonical receptor, enzyme, or transporter.
Enhancement of mitochondrial energy production; Reduction of oxidative stress; Modulation of ion channels (Ca²⁺, H⁺, Na⁺); Inhibition or activation of signaling pathways (cAMP, protein kinases)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm motility and viability.